Schmid John P.

Average Profitability
<0.0001%
Insider Buys Quantity
7
Insider Buys Sum
$149,868.52
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Schmid John P.

According to the SEC Form 4 filings, Schmid John P., being in a position of

  1. director at Design Therapeutics, Inc.,
    оver the last 12 months, has bought 26965 shares for $99,738, and sold 0 shares,
    over all time since 2024-03-22, has bought 26965 shares for $99,738, and sold 0 shares.

The largest purchase of all time was on 2024-03-25 and amounted to 17809 shares of Design Therapeutics, Inc. for $66,606.

Biography of Schmid John P.

No biography is available at this moment.

2024-08-12PurchaseXeris Biopharma Holdings, Inc.
XERS
director
4,515
0.003%
$2.25$10,147+28%
2024-08-09PurchaseXeris Biopharma Holdings, Inc.
XERS
director
4,285
0.0029%
$2.37$10,134+24.14%
2024-05-10PurchaseXeris Biopharma Holdings, Inc.
XERS
director
5,400
0.004%
$1.91$10,314+45.45%
2024-03-25PurchaseDesign Therapeutics, Inc.
DSGN
director
17,809
0.0318%
$3.74$66,606+17.51%
2024-03-22PurchaseDesign Therapeutics, Inc.
DSGN
director
9,156
0.0156%
$3.62$33,133+14.62%
2024-03-14PurchaseXeris Biopharma Holdings, Inc.
XERS
director
4,500
0.0032%
$2.16$9,720+5.63%
2023-11-16PurchaseXeris Biopharma Holdings, Inc.
XERS
director
6,500
0.0045%
$1.51$9,815+47.47%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.